VERRICA PHARMACEUTICALS INC (VRCA)
US92511W1080 - Common Stock
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 22.96M | 69.55M | 34.27M | 15.75M | 10.69M | |||
| Marketable Securities | N/A | N/A | 0.00 | 54.60M | 54.78M | |||
| Receivables | 84.00K | 4.42M | 490.00K | N/A | N/A | |||
| Inventories | 2.58M | 1.02M | N/A | N/A | N/A | |||
| Other Current Assets | 2.56M | 2.54M | 4.36M | 3.97M | 2.18M | |||
| Total Current Assets | 28.19M | 77.53M | 39.12M | 74.33M | 67.65M | |||
| Non-Current Assets | ||||||||
| PPE Net | 4.20M | 3.62M | 5.33M | 5.50M | 4.94M | |||
| Other Non-Current Assets | 538.00K | 452.00K | 280.00K | 300.00K | 1.57M | |||
| Total Non-Current Assets | 4.74M | 4.07M | 5.60M | 5.80M | 6.50M | |||
| TOTAL ASSETS | 32.93M | 81.60M | 44.72M | 80.13M | 74.15M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 846.00K | 376.00K | 0.00 | 41.70M | 35.32M | |||
| Accrued Expenses | 18.79M | 14.18M | 2.95M | 3.51M | 3.31M | |||
| Accounts Payable | 966.00K | 2.46M | 510.00K | 850.00K | 350.00K | |||
| Other Current Liabilities | 428.00K | N/A | N/A | 0.00 | 500.00K | |||
| Total Current Liabilities | 21.03M | 17.02M | 3.46M | 46.06M | 39.48M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 45.29M | 43.90M | 0.00 | 20.00K | 0.00 | |||
| Other Non-Current Liabilities | 665.00K | 910.00K | 1.23M | 1.45M | 1.69M | |||
| Total Non-Current Liabilities | 45.95M | 44.81M | 1.23M | 1.46M | 1.69M | |||
| TOTAL LIABILITIES | 66.98M | 61.83M | 4.69M | 47.52M | 41.17M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -290.82M | -230.45M | -163.45M | -138.97M | -103.89M | |||
| Additional Paid In Capital | 256.77M | 250.21M | 203.48M | 171.60M | 136.87M | |||
| Common Shares | 5.00K | 4.00K | 0.00 | 0.00 | 0.00 | |||
| Treasury Stock | 0.00 | 0.00 | N/A | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -34.05M | N/A | N/A | -30.00K | 0.00 | |||
| Shares Outstanding | 45.60M | 42.41M | 41.09M | 27.52M | 25.44M | |||
| Tangible Book Value per Share | -0.75 | 0.47 | 0.97 | 1.19 | 1.30 | |||
| Total Shareholders' Equity | -34.05M | 19.76M | 40.03M | 32.61M | 32.99M | |||
| TOTAL LIABILITIES AND EQUITY | 32.93M | 81.60M | 44.72M | 80.13M | 74.15M | |||
| Statistics | ||||||||
| Debt/Equity | -1.33 | 2.22 | N/A | 0.00 | N/A | |||
| Current Ratio | 1.34 | 4.55 | 11.31 | 1.61 | 1.71 | |||
| Return On Assets (ROA) | -258.12% | -82.10% | -54.76% | -43.78% | -57.57% | |||
| Return On Equity (ROE) | N/A | -338.99% | -61.18% | -107.57% | -129.40% | |||
All data in USD , ROIC based on taxRate of 0.21